129 related articles for article (PubMed ID: 21796059)
1. Dual oral antiplatelet therapy and unplanned surgery: possible role for intravenous platelet glycoprotein receptor inhibitors.
Bollati M; Giraudi E; Moretti C; Millesimo G; Sciuto F; Omedè P; Biondi Zoccai G; Sheiban I
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):673-4. PubMed ID: 21796059
[No Abstract] [Full Text] [Related]
2. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
3. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.
D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078
[TBL] [Abstract][Full Text] [Related]
4. [The CURRENT-OASIS 7 study].
Ardissino D; Patti G; Magnani G; Mantovani F; Demola MA
G Ital Cardiol (Rome); 2011 Mar; 12(3):167-71. PubMed ID: 21560471
[No Abstract] [Full Text] [Related]
5. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
Collet JP; Montalescot G; Steg PG; Steinhubl SR; Fox KA; Hu TF; Johnston SC; Hamm CW; Bhatt DL; Topol EJ
Arch Cardiovasc Dis; 2009; 102(6-7):485-96. PubMed ID: 19664568
[TBL] [Abstract][Full Text] [Related]
6. Non-cardiac surgery in patients with coronary stents: the RECO study.
Albaladejo P; Marret E; Samama CM; Collet JP; Abhay K; Loutrel O; Charbonneau H; Jaber S; Thoret S; Bosson JL; Piriou V
Heart; 2011 Oct; 97(19):1566-72. PubMed ID: 21791513
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
Leopold JA; Antman EM
Circulation; 2005 Mar; 111(9):1097-9. PubMed ID: 15753225
[No Abstract] [Full Text] [Related]
8. [New antiaggregants and their importance for the practitioner].
Tsakiris DA
Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
[TBL] [Abstract][Full Text] [Related]
9. Conversation with an expert. Plavix: what you need to know.
O'Gara P
Harv Heart Lett; 2011 Jan; 21(5):3. PubMed ID: 21322911
[No Abstract] [Full Text] [Related]
10. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
[TBL] [Abstract][Full Text] [Related]
11. Platelet inhibition strategies in percutaneous coronary intervention: competition or coopetition?
Tcheng JE; Campbell ME
J Am Coll Cardiol; 2003 Oct; 42(7):1196-8. PubMed ID: 14522479
[No Abstract] [Full Text] [Related]
12. Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study.
El Khoury C; Dubien PY; Mercier C; Belle L; Debaty G; Capel O; Perret T; Savary D; Serre P; Bonnefoy E;
Arch Cardiovasc Dis; 2010 May; 103(5):285-92. PubMed ID: 20619238
[TBL] [Abstract][Full Text] [Related]
13. Combined antithrombotic therapy for acute coronary syndrome.
Gawaz M; Müller I; Besta F
Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
[TBL] [Abstract][Full Text] [Related]
15. [Spleen rupture in myocardial infarction after administration of GP IIb-IIIa-antagonists].
Feldmann C; Deutsch HJ
Dtsch Med Wochenschr; 2005 Jan; 130(1-2):29-30. PubMed ID: 15619171
[No Abstract] [Full Text] [Related]
16. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
18. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
20. Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?
Adam PC; Pemberton J; Evemy KL
Lancet; 2001 May; 357(9267):1535-6. PubMed ID: 11386297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
